No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
MORF240719P20000
- 0.05
- -1.00-95.24%
15min DelayClose Jul 8 15:54 ET
0.05High0.05Low
0.05Open1.05Pre Close10 Volume16 Open Interest20.00Strike Price50.00Turnover258.33%IV64.21%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier10DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type-0.0055Delta0.0006Gamma1114.80Leverage Ratio-0.0163Theta-0.0001Rho-6.16Eff Leverage0.0015Vega
Intraday
- 5D
- Daily
News
Eli Lilly Strikes $3.2 Billion Deal to Acquire Morphic
Eli Lilly (LLY) will buy biopharmaceutical company Morphic (MORF) for roughly $3.2 billion in a bid to expand its immunology portfolio with oral therapies targeting cell proteins for chronic diseases.
Express News | RBC Capital Downgrades Morphic Holding to Sector Perform, Lowers Price Target to $57
Morphic Holding Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 07/09/2024 1.42% RBC Capital $70 → $57 Downgrades Outperform → Sector Perform 03/08/2024 17.44%
TD Cowen Downgrades Morphic Holding to Hold From Buy
Morphic Holding (MORF) has an average rating of outperform and price targets ranging from $30 to $64, according to analysts polled by Capital IQ.Price: 55.80, Change: +0.06, Percent Change: +0.11
Morphic Holding Acquisition Prospects: A Balanced Hold Rating Amid Lilly's Offer and Pipeline Potential
Express News | Morphic Holding Inc : BMO Raises Target Price to $57 From $52
Comments
$Eli Lilly and Co(LLY.US$ recent larger M&A: $Morphic(MORF.US$ , $PNT, $DICE, Versanis
Common theme: all bought post-POM, pre-POC / full de-risking. Higher clinical risk, offset by lower price
$LLY is uniquely positioned to employ such a strategy right now; admirable to see mgmt recognize & leverage that
Common theme: all bought post-POM, pre-POC / full de-risking. Higher clinical risk, offset by lower price
$LLY is uniquely positioned to employ such a strategy right now; admirable to see mgmt recognize & leverage that
1
Morning Movers
Gapping up
$Boeing(BA.US$ stock rose 0.90% after the aircraft manufacturer agreed to plead guilty to a criminal fraud conspiracy charge to resolve a U.S. Justice Department investigation into two 737 MAX fatal crashes and will pay a $243.6 million fine.
$Paramount Global-B(PARA.US$ stock rose 2.87% after Skydance Media agreed to acquire the entertainment giant, with the overall deal valued at over $8 billion....
Gapping up
$Boeing(BA.US$ stock rose 0.90% after the aircraft manufacturer agreed to plead guilty to a criminal fraud conspiracy charge to resolve a U.S. Justice Department investigation into two 737 MAX fatal crashes and will pay a $243.6 million fine.
$Paramount Global-B(PARA.US$ stock rose 2.87% after Skydance Media agreed to acquire the entertainment giant, with the overall deal valued at over $8 billion....
Expand 36
5
$Morphic(MORF.US$ soo very high
Insider buying paints a hopeful picture for Morphic Holding's future despite losses. High ownership by insiders hints at alignment with shareholders' interests, possibly seeing the current stock price as low.
Read more